Genetically engineered bacteria may be useful for delivery of mucolytics into cystic fibrosis lungs

Med Hypotheses. 2006;67(2):426-7. doi: 10.1016/j.mehy.2006.03.013. Epub 2006 May 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cystic Fibrosis / therapy*
  • Deoxyribonuclease I / genetics
  • Expectorants / metabolism*
  • Gelsolin / genetics
  • Genetic Engineering*
  • Humans
  • Lung Diseases / therapy*
  • Pseudomonas aeruginosa / genetics*
  • Pseudomonas aeruginosa / metabolism

Substances

  • Expectorants
  • Gelsolin
  • DNASE1 protein, human
  • Deoxyribonuclease I